Option Care Health (OPCH) FY2016 results: revenue $936 million, down 48.5% on the year
Option Care Health, Inc. (OPCH) reported revenue of $936 million for fiscal 2016, the year ended 31 December 2016, down 48.5% on the year before. Net income was -$43 million, and diluted earnings per share $-0.54. The figures are the company's own, from the 10-K it filed with the SEC on 15 March 2019.
Revenue
$936 million
-48.5% on the year
FY2007FY2016
Operating margin
-1.2%
1.4% a year earlier
FY2007FY2016
Net income
-$43 million
FY2007FY2016
Diluted EPS
-$0.54
FY2007FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2011
FY2009
On the year
Last 8 years
Revenue
936
1,818
1,330
-48.5%
Cost of revenue
674
339
1,172
+98.6%
Gross profit
262
215
158
+21.7%
Gross margin
28.0%
11.8%
11.9%
Operating income
-11.0
25.6
15.5
Operating margin
-1.2%
1.4%
1.2%
Interest expense
n/a
25.5
1.9
Pre-tax income
-34.2
0.0
13.5
Income tax
2.0
0.4
-40.6
+363.2%
Effective tax rate
n/a
3954.5%
-299.4%
Net income
-42.8
7.9
54.1
Net margin
-4.6%
0.4%
4.1%
Diluted EPS
-$0.54
$0.14
$1.36
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2011
FY2009
On the year
Last 8 years
Operating cash flow
-42.5
27.0
22.7
Capital expenditure
9.9
0.5
0.0
+2,031.7%
Free cash flow
-52.4
26.5
22.7
Free cash flow margin
-5.6%
1.5%
1.7%
Cash from investing
-73.2
-9.9
-5.7
Cash from financing
110
-17.1
-17.0
Depreciation and amortisation
22.0
10.0
5.0
+121.0%
Share-based compensation
1.8
4.5
3.4
-59.7%
Diluted shares, weighted
n/a
55m
40m
Shares outstanding at period end
118m
55m
40m
+113.5%
Balance sheet
$ million
FY2016
FY2011
FY2009
On the year
Last 8 years
Shareholders' equity
601
215
156
+179.1%
Short-term borrowings
n/a
n/a
0.0
Debt
468
293
0.0
+59.4%
Other liabilities
n/a
168
131
Total liabilities and equity
605
677
287
-10.7%
Fixed assets
32.7
27.0
15.5
+21.2%
Goodwill
366
312
24.5
+17.1%
Intangible assets
31.0
19.6
0.0
+58.2%
Cash and equivalents
9.6
0.0
0.0
Receivables
109
225
151
-51.6%
Inventory
36.2
18.0
51.3
+101.0%
Other assets
20.5
74.7
44.9
-72.6%
Total assets
605
677
287
-10.7%
10-K for the year ended 31 December 2016, filed 15 March 2019: the filing.